This trial is completed!
Search for a recruiting clinical trial for your condition
You can access this
clinical trial
if you have
Thyroid Cancer
and you are
over 20
years old
Phase
2
This is a second phase trial assessing
efficacy and side effects of the new treatment.
Show me locations

The purpose

This study is to evaluate the safety, efficacy, and pharmacokinetics of E7080 when orally administered once daily (QD) in subjects with advanced thyroid cancer.

Provided treatments

  • Drug: E7080 capsule
Tris trial is registered with FDA with number: NCT01728623. The sponsor of the trial is Eisai Co., Ltd. and it is looking for 37 volunteers for the current phase.
Official trial title:
A Phase 2 Study of E7080 in Subjects With Advanced Thyroid Cancer